We have 3 of 40 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
[This corrects the article DOI: 10.3389/fsurg.2026.1871976.].
A novel bispecific ANXA2/CD147 CAR-T cell was developed to provide an experimental basis for improving the therapeutic outcome of osteosarcoma and generated a bispecific ANXA2/CD147 CAR-T cell with robust antitumor activity, providing a promising new strategy for the immunotherapy of osteosarcoma.
ScGPA provides a practical workflow system for predicting and prioritizing direction-specific downstream transcriptional responses after target-gene perturbation, and supports target-gene function inference and downstream mechanistic investigation from single-cell transcriptomic data.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
